Skip to main content
. 2021 Feb 22;45(4):38. doi: 10.3892/or.2021.7989

Figure 1.

Figure 1.

CK inhibits the proliferation of RCC cells. (A) The viability of Caki-1 and 786-O cells was measured via an MTT assay after exposure to various doses of CK for different times. (B) A colony formation assay was performed to measure the proliferative activity of RCC cells after treatment with various doses of CK. The data are presented as the mean ± SD of at least three independent experiments. *P<0.05, **P<0.01 and ***P<0.001 vs. control group. CK, ginsenoside compound K; RCC, renal cell carcinoma.